CompuMed (OTCMKTS:CMPD) Trading Down 0.3% – What’s Next?

CompuMed Inc. (OTCMKTS:CMPDGet Free Report)’s share price was down 0.3% during mid-day trading on Wednesday . The company traded as low as $6.00 and last traded at $6.70. Approximately 1,092 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 818 shares. The stock had previously closed at $6.72.

CompuMed Price Performance

The business’s 50-day moving average price is $6.38 and its 200 day moving average price is $5.81. The company has a market capitalization of $8.91 million, a P/E ratio of -44.66 and a beta of -0.47. The company has a quick ratio of 2.34, a current ratio of 2.37 and a debt-to-equity ratio of 0.12.

CompuMed (OTCMKTS:CMPDGet Free Report) last posted its earnings results on Monday, May 11th. The company reported ($0.06) earnings per share for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.The firm had revenue of $2.03 million for the quarter.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Articles

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.